Latest Equities News

Judo Bank reported a robust first half of FY25, delivering a 33% increase in underlying profit before tax driven by strong lending growth and improved margins. The bank is advancing its regional expansion with plans for 10 new locations and 20 additional bankers in FY25.

Judo Bank has reported a robust half-year performance with a 70% jump in statutory net profit, driven by strong loan growth and improved margins, while reaffirming its FY25 profit guidance.

Judo Capital Holdings Limited reported a robust 54% increase in statutory profit before tax for the half year ended December 2024, driven by strong SME loan growth and prudent cost management, despite a slight dip in net interest margin and statutory profit after tax.

Morphic Ethical Equities Fund Limited reported a robust turnaround with a $2.96 million profit after tax for the half-year ended December 2024, reversing last year’s losses despite no dividends declared.

Citigroup Global Markets Australia has announced a partially franked dividend of AUD 2.15 for COH CitiFirst Instalments, with key dates set for March and April 2025.

Health and Plant Protein Group Limited reported a significantly reduced net loss of $43,000 for the half-year ended December 31, 2024, compared to a $748,000 loss in the prior period, despite no operational revenue following the sale of its macadamia division.

VanEck Investments Limited has released its indicative dividends calendar for 2025, outlining expected dividend timings for over 50 exchange-traded funds (ETFs). This comprehensive schedule offers investors clarity on dividend announcements, ex-dates, and payment dates across a diverse range of funds.

Eagle Mountain Mining has completed a significant capital raise through the issue of over 518 million new shares and 129 million options, including a $3 million loan conversion, bolstering its exploration projects in Arizona.

Althea Group Holdings has raised $4 million through a share and loan note placement to boost its THC beverage production and infrastructure across North America, targeting rapid growth in the U.S. and Canada.

PYC Therapeutics has launched a A$145.8 million pro-rata accelerated non-renounceable entitlement offer to fund late-stage clinical trials across its pipeline targeting rare diseases with high unmet needs. The capital raise aims to extend the company’s cash runway beyond FY27, supporting four drug candidates through critical human safety and efficacy milestones.

Havilah Resources has completed a 7,511-metre drilling program at its Mutooroo copper-cobalt-gold project, revealing promising extensions beyond the current resource envelope. Collaborative efforts with JX Advanced Metals Corporation advance metallurgical and mining studies, underpinning a potential resource upgrade.

PYC Therapeutics is set to raise up to $146 million through a pro-rata entitlement offer, aiming to accelerate its RNA-based drug candidates targeting major unmet medical needs. Major shareholder support and underwriting commitments underpin the capital raise.